The Union Health Ministry on Thursday termed as ‘misleading’ and ‘fallacious’ media reports which claimed that regulatory approval for Covid-19 vaccine Covaxin was rushed due to political pressure. It said scientific approach and prescribed norms were adhered to in approving Covid-19 vaccines for emergency use authorisation.
There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous Covid-19 vaccine Covaxin, ‘had to skip certain processes’ and ‘speed’ up clinical trials due to political pressure, the ministry said.
While Bharat Biotech, the Covid-19 vaccine Covaxin maker on Thursday said there was no external pressure on the firm to speed up its development. In a press release, the vaccine maker said with several hundred million doses administered worldwide, Covid-19 vaccine Covaxin has demonstrated an excellent safety record with minimal adverse events and no vaccine-associated cases detected for myocarditis or thrombocytopenia.
“There was no external pressure to accelerate development of Covaxin,” it said, adding the pressure was all internal to develop a safe and effective vaccine for the Covid-19 pandemic, to save lives and livelihoods in India and globally. PTI